Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Long‐acting Muscarinic Antagonists (LAMA) Added to Inhaled Corticosteroids (ICS) Versus Higher Dose ICS for Adults With Asthma." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434100/all/images/google-play-badge.png. Accessed 16 May 2024.
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434100/all/images/google-play-badge.png. Accessed May 16, 2024.
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434100/all/images/google-play-badge.png
Long‐acting Muscarinic Antagonists (LAMA) Added to Inhaled Corticosteroids (ICS) Versus Higher Dose ICS for Adults With Asthma [Internet]. In: Cochrane Abstracts. [cited 2024 May 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434100/all/images/google-play-badge.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma
ID - 434100
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434100/all/images/google-play-badge.png
DB - Evidence Central
DP - Unbound Medicine
ER -